The initial public offering for Saroja Pharma Industries IPO GMP began Thursday ( 31 August 2023) and will end on Tuesday, 5 September 2023. The price range for the IPO has been established by the firm at ₹84 per equity share, and on September 13, 2023, the share will begin trading on the NSE SME platform. According to the face value of a ₹10 note, the corporation has set the price of its IPO at ₹84. Through this public offering of 1,084,800 equity shares, the firm will raise ₹9.11 crores, and the offer is a 100% fixed price issue. In this IPO, the corporation reserves a quota of 50% for NII and 50% for retail investors.
Saroja Pharma Industries IPO GMP
The 9.11 crore-dollar Saroja Pharma IPO is entirely a new offering; there is no offer for sale (OFS) component. The firm intends to utilize the net proceeds from the offering to pay for the following objectives, including the establishment of a production facility, debt repayment, and public issue costs. On Friday, shares for Saroja Pharma Industries IPO GMP’s first public offering will be allocated. On Tuesday, September 12, those who were awarded shares will get them in their Demat accounts. On Monday, September 11, the refunding procedure for individuals who did not get shares will start.
- Vishnu Prakash IPO Allotment Status
- Rajmarg Yatra app
- Sahara Refund Portal
|IPO Opening Dates
|31 Aug 2023
|IPO Closing Dates
|05 Sep 2023
|Total IPO size
|Minimum bid (lot size)
|10 INR Per Share
The trading, exporting, and supply operations of Saroja Pharma Industries IPO GMP India Limited are concentrated on specialty chemicals & API. Chemical, pharmaceutical intermediate, and veterinary pharmaceutical API are the three main areas in which the company excels. The company sells a variety of medications, some of which are API solvents, used for human and veterinary therapies, along with Liquide Bromine, used as an agro-intermediate, Ethyl Acetate, used as an API solvent, and other products.
Saroja Pharma Industries IPO subscription status
On day 1, 79% of the IPO subscriptions for Saroja Pharma Industries were received. According to statistics on Chittorgarh.com, the offer had a favorable reaction from individual investors, whose part set was subscribed 1.58 times, and non-institutional purchasers, whose portion set was subscribed 11%.
According to information on chittorgarh.com, the business has received offers for 8,12,800 shares compared to the 1,084,800 shares that are being offered.
How to apply for Saroja Pharma Industries IPO GMP through Zerodha?
Customers of Zerodha may apply online with a UPI payment link for Saroja Pharma Industries’ IPO GMP. By entering into the Zerodha Console (back office) and completing an IPO application form, Zerodha users may apply for the Saroja Pharma Industries IPO.
Application procedures for the Zerodha IPO of Saroja Pharma Industries
- Log in to the Console by visiting the Zerodha website.
- Click the IPO link under Portfolio.
- Go to the ‘Saroja Pharma Industries IPO GMP’ row and choose ‘Bid’.
- Enter the Price, Quantity, and UPI ID.
- “Submit” your IPO application.
- To approve the requirement, go into the UPI App (or BHIM or online banking).
Saroja Pharma IPO GMP today
According to topsharebrokers.com, the Saroja Pharma IPO GMP today or grey market premium on Thursday was 0, which means that shares were trading at their 84 issue price with no premium or discount.
Investors’ willingness to pay more than the issue price is indicated by the term “grey market premium.”
Objects of the Issue
The proceeds from the most recent issue will go toward the following goals:
- To set up a Manufacturing Unit.
- To Repay the Unsecured Loans.
- Public Issue Expenses.
- Experienced Promoters and Management Team
- Scalable Business Model
- A wide and diverse range of product offerings
- Diversified business operations and revenue base
IPO grey market premium (GMP)
The price at which an initial public offering (IPO) is sold on an unofficial/illegal grey market before it is listed is known as the grey market premium (GMP). The GMP depicts possible outcomes for an IPO offering from a specific firm on the day of listing. When the GMP premium is positive, the IPO is expected to be profitable, but when it is negative, the IPO is probably being offered at a bargain.
A dangerous investment choice would be one based entirely on Saroja Pharma Industries SME IPO GMP since it should be highlighted that IPO GMP is quite volatile. Therefore, before investing, carefully weigh all the relevant information and decide whether to support Saroja Pharma Industries’ SME IPO or not.